Watchlist Price Alert

Crinetics Pharmaceuticals... (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

29.80

0.36 (1.22%)

At close: Jul 03, 2025, 1:45 PM

Crinetics Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	264.55M	54.9M	32.67M	200.69M	93.09M	40.33M	44.97M	14.19M	12.15M
Short-Term Investments	1.09B	503.66M	301.75M	133.01M	77.79M	78.07M	118.9M	n/a	n/a
Long-Term Investments	n/a	1.77M	1.97M	1.01M	500K	500K	500K	n/a	n/a
Other Long-Term Assets	3.63M	2M	37K	568K	40K	82K	n/a	33K	10K
Receivables	8.47M	9.35M	n/a	2.03M	1.83M	n/a	n/a	734K	72K
Inventory	n/a	n/a	n/a	8.07M	-1.83M	-1.38M	n/a	141K	98K
Other Current Assets	1.71M	1.58M	7.25M	n/a	1.02M	n/a	n/a	n/a	43K
Total Current Assets	1.38B	574.15M	345.18M	344.72M	177.49M	123.34M	166.68M	15.16M	12.37M
Property-Plant & Equipment	55.58M	57.43M	4.99M	4.72M	5.41M	6.46M	4.23M	400K	224K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	59.2M	61.2M	6.99M	6.29M	5.95M	7.04M	4.73M	433K	234K
Total Assets	1.43B	635.35M	352.18M	351.01M	183.44M	130.38M	171.41M	15.6M	12.6M
Account Payables	5.85M	6.55M	6.88M	3.42M	3.49M	2.7M	1.46M	403K	340K
Deferred Revenue	2.18M	2.06M	2.24M	-939K	-835K	-724K	n/a	n/a	n/a
Short-Term Debt	7.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	49K
Other Current Liabilities	28.89M	16.65M	8.47M	93K	835K	724K	590K	n/a	n/a
Total Current Liabilities	59.68M	43.94M	27.72M	15.99M	10.49M	8.34M	7.92M	897K	890K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	163K
Other Long-Term Liabilities	829K	n/a	n/a	2K	23K	49K	3.27M	29.72M	17.75M
Total Long-Term Liabilities	50.1M	52.3M	8.13M	3.08M	4.04M	4.9M	3.27M	29.72M	17.91M
Total Liabilities	109.79M	96.25M	35.85M	19.07M	14.53M	13.24M	11.19M	30.62M	18.8M
Total Debt	51.72M	51.73M	2.02M	3.07M	4.01M	4.85M	n/a	n/a	212K
Common Stock	2.28B	1.19B	759.43M	607.58M	336.51M	210.79M	24K	1K	1K
Retained Earnings	-952.11M	-653.7M	-439.17M	-275.25M	-167.61M	-93.8M	-43.38M	-16.27M	-7.11M
Comprehensive Income	963K	977K	-3.93M	-382K	25K	148K	61K	-304K	-182K
Shareholders Equity	1.32B	539.11M	-439.17M	-275.25M	-167.61M	-93.8M	-43.38M	-15.02M	-6.2M
Total Investments	1.09B	505.43M	301.75M	134.02M	77.79M	78.07M	118.9M	n/a	n/a